- Cardio-Renal Metabesity (1)
- Cardiometabolic (1)
- Diabesity (8)
- Oral Semaglutide 25 mg Shows Significant Weight Loss in Adults With Overweight or Obesity
- Non-Surgical Fat Loss Techniques: Current Approaches and Clinical Considerations
- Ecnoglutide Shows Promising Weight Loss Results in New Phase 3 Trial
- Semaglutide in Type 1 Diabetes and Obesity: A Promising New Direction for Dual Disease Management
- Dual Blockade in Diabetic Kidney Disease: Early Evidence Supports Combined Finerenone and Empagliflozin Therapy
